Found 5 matching trials
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease PHASE2 The primary objective of this study is to determine the effect of selonsert...
Show More Location
The University of Alabama at Birmingham (UAB)
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) PHASE2 The primary objectives of this study are:
* To assess the safety and toler...
Show More Location
The Institute for Liver Health
Learn More & Join Trial
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis PHASE3 The primary objective of this study is to evaluate whether selonsertib (SEL...
Show More Location
Institute of Liver Health
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease PHASE2 The primary objective of this study is to evaluate whether selonsertib (SEL...
Show More Location
Arizona Kidney Disease and Hypertension Centers
Learn More & Join Trial
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) PHASE3 The primary objective of this study is to evaluate whether selonsertib (SEL...
Show More Location
Institute of Liver Health
Learn More & Join Trial